{"id":"placebo-life-style-counselling","safety":{"commonSideEffects":[{"rate":null,"effect":"Minimal adverse events expected"}]},"_chembl":{"chemblId":"CHEMBL589586","moleculeType":"Small molecule","molecularWeight":"130.10"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"This intervention combines an inert placebo with structured lifestyle counseling (diet, exercise, stress management, etc.). The mechanism operates through both the placebo effect (expectancy and conditioning) and the direct physiological benefits of lifestyle changes. The counseling component addresses modifiable risk factors while the placebo may enhance adherence and perceived benefit through psychological pathways.","oneSentence":"Placebo combined with lifestyle counseling works through behavioral modification and expectancy effects to improve health outcomes.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T00:01:05.499Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Lifestyle-related chronic disease prevention and management (e.g., metabolic syndrome, hypertension, obesity)"}]},"trialDetails":[{"nctId":"NCT05933499","phase":"PHASE2","title":"Effect of Tirzepatide and Bimagrumab on Body Composition, Insulin Sensitivity, and Bone in Adults With Obesity","status":"RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2025-11-05","conditions":"Obesity","enrollment":63},{"nctId":"NCT07481747","phase":"PHASE3","title":"Efficacy and Safety of Tirzepatide Once Weekly Versus Placebo in Participants Who Are Either Obese or Overweight With Weight-Related Comorbidities (SURMOUNT-1)","status":"RECRUITING","sponsor":"Hudson Biotech","startDate":"2026-02-02","conditions":"Obesity, Overweight (Without Type 2 Diabetes) With Weight-related Comorbidities","enrollment":2539},{"nctId":"NCT07481734","phase":"PHASE2","title":"Tesamorelin for Reduction of Liver Fat in Adults With Fatty Liver Disease (Mock Study)","status":"RECRUITING","sponsor":"Hudson Biotech","startDate":"2026-02-02","conditions":"Metabolic Associated Steatotic Liver Disease, Nonalcoholic Steatohepatitis, Hepatic Steatosis","enrollment":120},{"nctId":"NCT07467447","phase":"PHASE2","title":"Effect of LY3437943 Versus Placebo in Participants Who Have Obesity or Are Overweight","status":"RECRUITING","sponsor":"Hudson Biotech","startDate":"2026-02-15","conditions":"Obesity","enrollment":300},{"nctId":"NCT04153136","phase":"PHASE2","title":"The ENCHANTMENT HIV Study","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2020-09-11","conditions":"HIV/AIDS, Heart Failure With Preserved Ejection Fraction","enrollment":39},{"nctId":"NCT07214974","phase":"EARLY_PHASE1","title":"Mild Cognitive Impairment Community Screening and Early Intervention Via Stem Cell Therapy and Wearable Brain Computer Interface Device.","status":"NOT_YET_RECRUITING","sponsor":"Noah Tech, Corp.","startDate":"2026-09-01","conditions":"Mild Cognitive Impairment (MCI), Early Stages of Cognitive Decline, Alzheimer's Disease Dementia","enrollment":600},{"nctId":"NCT05371496","phase":"PHASE2","title":"Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction","status":"ENROLLING_BY_INVITATION","sponsor":"Mayo Clinic","startDate":"2022-09-06","conditions":"Cardiomyopathy, Heart Failure With Preserved Ejection Fraction (HFpEF), Obesity","enrollment":81},{"nctId":"NCT07220759","phase":"PHASE3","title":"Weight Loss in People Living With Overweight or Obesity and Type 2 Diabetes Following Treatment With Cagrilintide","status":"ACTIVE_NOT_RECRUITING","sponsor":"Novo Nordisk A/S","startDate":"2025-11-05","conditions":"Overweight, Obesity, Type 2 Diabetes","enrollment":330},{"nctId":"NCT07220642","phase":"PHASE3","title":"Weight Loss in People Living With Overweight or Obesity Following Treatment With Cagrilintide","status":"ACTIVE_NOT_RECRUITING","sponsor":"Novo Nordisk A/S","startDate":"2025-11-05","conditions":"Obesity, Overweight","enrollment":300},{"nctId":"NCT05975580","phase":"PHASE4","title":"Pharmacotherapy in Conjunction With Lifestyle Counseling for Management of Weight Regain After Bariatric Surgery","status":"RECRUITING","sponsor":"University of California, Irvine","startDate":"2023-08-29","conditions":"Obesity","enrollment":120},{"nctId":"NCT03229057","phase":"PHASE3","title":"Comparing the Effects of Oral Contraceptive Pills Versus Metformin","status":"COMPLETED","sponsor":"Anuja Dokras","startDate":"2018-01-15","conditions":"PCOS","enrollment":240},{"nctId":"NCT06348628","phase":"NA","title":"Motivational Interviewing in the Management of Non Alcoholic Fatty Liver Disease","status":"COMPLETED","sponsor":"Madunil Anuk Niriella","startDate":"2022-05-31","conditions":"Non-Alcoholic Fatty Liver Disease","enrollment":231},{"nctId":"NCT05548647","phase":"PHASE4","title":"Semaglutide Treatment, Appetite, and Eating Behavior: Long-term Effects","status":"COMPLETED","sponsor":"University of Pennsylvania","startDate":"2022-07-26","conditions":"Obesity","enrollment":120},{"nctId":"NCT06999577","phase":"PHASE4","title":"The Mechanism Versus PPI Trial","status":"RECRUITING","sponsor":"University of California, San Diego","startDate":"2025-06-04","conditions":"Laryngopharyngeal Reflux, Cough, Throat Clearing","enrollment":160},{"nctId":"NCT06054035","phase":"PHASE4","title":"SGLT2 Inhibition in Addition to Lifestyle Intervention and Risk for Complications in Subtypes of Patients With Prediabetes","status":"RECRUITING","sponsor":"University Hospital Tuebingen","startDate":"2023-10-26","conditions":"Type2diabetes, PreDiabetes, Renal Failure","enrollment":170},{"nctId":"NCT04007393","phase":"PHASE2","title":"SMART Use of Medication for the Treatment of Adolescent Severe Obesity","status":"COMPLETED","sponsor":"University of Minnesota","startDate":"2019-11-21","conditions":"Adolescent Obesity","enrollment":150},{"nctId":"NCT06826807","phase":"NA","title":"Hepatic Elastography-Enhanced Lifestyle Modification in MASLD","status":"ENROLLING_BY_INVITATION","sponsor":"Mahidol University","startDate":"2025-05-12","conditions":"Transient Elastography, MASLD, BMI","enrollment":92},{"nctId":"NCT06078748","phase":"NA","title":"The Lifestyle Exercise and Diet Trial (LEAD) 2.0","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Waterloo","startDate":"2023-10-03","conditions":"Subjective Cognitive Decline","enrollment":140},{"nctId":"NCT03807310","phase":"NA","title":"Targeted Nutrient Supplement in COPD (NUTRECOVER-trial)","status":"RECRUITING","sponsor":"Maastricht University Medical Center","startDate":"2020-02-19","conditions":"Pulmonary Disease, Chronic Obstructive","enrollment":166},{"nctId":"NCT04222322","phase":"NA","title":"The Effect of Epitomee Capsule on Body Weight in Patients With Overweight and Obesity","status":"COMPLETED","sponsor":"Epitomee medical","startDate":"2020-09-15","conditions":"Overweight and Obesity","enrollment":279},{"nctId":"NCT06314035","phase":"NA","title":"Decision Support on End-of-life Care Planning in Older Adults","status":"NOT_YET_RECRUITING","sponsor":"National Taipei University of Nursing and Health Sciences","startDate":"2024-03-10","conditions":"Chronic Obstructive Pulmonary Disease","enrollment":60},{"nctId":"NCT03978052","phase":"NA","title":"Prevention of Cognitive Decline in ApoE4 Carriers With Subjective Cognitive Decline After EGCG and a Multimodal Intervention","status":"COMPLETED","sponsor":"Parc de Salut Mar","startDate":"2019-10-30","conditions":"Alzheimer Disease, Cognitive Decline","enrollment":129},{"nctId":"NCT05834062","phase":"PHASE2","title":"Phentermine/Topiramate as Preventive Pharmacotherapy for Obesity","status":"WITHDRAWN","sponsor":"University of Minnesota","startDate":"2023-10-17","conditions":"Obesity, Adolescent","enrollment":""},{"nctId":"NCT02513888","phase":"NA","title":"Prevention of Type 2 Diabetes With Vitamin D Supplementation","status":"COMPLETED","sponsor":"Diabetes Foundation, India","startDate":"2013-02-01","conditions":"Prediabetes","enrollment":121},{"nctId":"NCT04025489","phase":"NA","title":"Vitamin D Supplementation on Surrogate Markers of Ageing, Ageing Genes, Glycemic and Metabolic Markers in North India","status":"UNKNOWN","sponsor":"Diabetes Foundation, India","startDate":"2020-03-01","conditions":"Vitamin D Supplementation, PreDiabetes, Aging","enrollment":200},{"nctId":"NCT02740179","phase":"NA","title":"Effects of Eplerenone on Cardiovascular Disease in HIV (MIRACLE HIV Study)","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2017-01","conditions":"HIV","enrollment":40},{"nctId":"NCT04721873","phase":"PHASE2","title":"Pharmacologic Weight Loss as Adjunct Therapy for Ulcerative Colitis in Obese Patients","status":"RECRUITING","sponsor":"University of California, San Diego","startDate":"2020-12-18","conditions":"Colitis, Ulcerative, Obesity","enrollment":40},{"nctId":"NCT05045326","phase":"NA","title":"Effectiveness of a Smoking Cessation Intervention in a Mental Health Day Hospital","status":"UNKNOWN","sponsor":"Hospital Clinic of Barcelona","startDate":"2021-05-30","conditions":"Tobacco Use Disorder, Smoking Cessation, Mental Disorder","enrollment":150},{"nctId":"NCT04650217","phase":"PHASE4","title":"Levodopa and Exercise for Older Adults With Depression and Psychomotor Slowing","status":"TERMINATED","sponsor":"New York State Psychiatric Institute","startDate":"2021-10-07","conditions":"Depressive Disorder","enrollment":1},{"nctId":"NCT04854083","phase":"PHASE4","title":"Semaglutide as an Adjunct to Dieting in the Treatment of Type 2 Diabetes","status":"UNKNOWN","sponsor":"Kirsi Pietiläinen","startDate":"2022-02-17","conditions":"Type2 Diabetes","enrollment":50},{"nctId":"NCT01775813","phase":"PHASE4","title":"The Health Influences of Puberty (HIP) Study","status":"COMPLETED","sponsor":"University of Colorado, Denver","startDate":"2011-06","conditions":"Obesity, Insulin Resistance, Gonadal Dysfunction","enrollment":104},{"nctId":"NCT05211817","phase":"NA","title":"Research on Prevention, Intervention and Mechanisms of Obesity and Its Comorbidities","status":"UNKNOWN","sponsor":"Slovak Academy of Sciences","startDate":"2021-11-01","conditions":"Obesity, Exercise, Nutrition, Healthy","enrollment":60},{"nctId":"NCT02369536","phase":"NA","title":"Efficacy of a Natural Components Mixture in the Treatment of Non Alcoholic Fatty Liver Disease (NAFLD)","status":"COMPLETED","sponsor":"Neuromed IRCCS","startDate":"2015-08-18","conditions":"Non-alcoholic Fatty Liver Disease","enrollment":126},{"nctId":"NCT01296516","phase":"NA","title":"Postpartum Weight Loss and Exercise (PRIDE)","status":"COMPLETED","sponsor":"Pennington Biomedical Research Center","startDate":"2011-02","conditions":"Gestational Diabetes, Glucose Intolerance","enrollment":7},{"nctId":"NCT01087411","phase":"NA","title":"Intervention Study to Prevent Obesity in Sedentary 8 Year Old Swedish Children","status":"WITHDRAWN","sponsor":"Karolinska Institutet","startDate":"2008-10","conditions":"Cardiovascular Risk Factors, Metabolic Risk Factors, Sedentary Lifestyle","enrollment":""},{"nctId":"NCT02972047","phase":"NA","title":"Understanding the Pathophysiology and Effects of Diaphragmatic Breathing in Upright Gastroesophageal Reflux","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2017-04-06","conditions":"GERD","enrollment":60},{"nctId":"NCT04525300","phase":"PHASE3","title":"Gut Microbiome Changes Following Liraglutide Treatment in Obese Subjects or Overweight Subjects With Co-morbidities","status":"UNKNOWN","sponsor":"Xiangya Hospital of Central South University","startDate":"2020-05-24","conditions":"Obesity","enrollment":300},{"nctId":"NCT04487743","phase":"PHASE3","title":"Efficacy and Safety of Liraglutide on Body Weight in Obese Subjects or Overweight Subjects With Co-morbidities","status":"UNKNOWN","sponsor":"Xiangya Hospital of Central South University","startDate":"2020-05-09","conditions":"Obesity","enrollment":300},{"nctId":"NCT03915808","phase":"NA","title":"The Effects of Supplementation of Conjugated Linoleic Acid on Body Fat Reduction","status":"COMPLETED","sponsor":"Jiaomei Yang","startDate":"2019-03-27","conditions":"Obesity, Adiposity","enrollment":66},{"nctId":"NCT02765581","phase":"NA","title":"Efficacy Study of Acupuncture in the Prevention of Migraine Without Aura","status":"COMPLETED","sponsor":"Wei Wang","startDate":"2016-05-01","conditions":"Migraine Without Aura","enrollment":150},{"nctId":"NCT02574767","phase":"NA","title":"Diet and Physical Activity Counseling and n3-long Chain (PUFA) Supplementation in Obese Pregnant Women","status":"COMPLETED","sponsor":"University of Chile","startDate":"2015-08","conditions":"Obesity, Pregnancy","enrollment":1002},{"nctId":"NCT02911818","phase":"PHASE4","title":"Lifestyle Modification and Liraglutide","status":"COMPLETED","sponsor":"University of Pennsylvania","startDate":"2016-09","conditions":"Obesity","enrollment":150},{"nctId":"NCT01405456","phase":"NA","title":"Eplerenone in HIV Associated Abdominal Fat Accumulation","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2012-01","conditions":"HIV","enrollment":46},{"nctId":"NCT01344135","phase":"NA","title":"Nutritional Rehabilitation in Chronic Obstructive Pulmonary Disease (COPD) Patients With Muscle Atrophy","status":"COMPLETED","sponsor":"Maastricht University Medical Center","startDate":"2011-09","conditions":"Pulmonary Disease, Chronic Obstructive, Muscular Atrophy","enrollment":81},{"nctId":"NCT02216552","phase":"PHASE2, PHASE3","title":"Resveratrol for the Treatment of Non Alcoholic Fatty Liver Disease and Insulin Resistance in Overweight Adolescents","status":"COMPLETED","sponsor":"University of Manitoba","startDate":"2015-08","conditions":"NAFLD, TYPE 2 DIABETES, METABOLIC SYNDROME","enrollment":10},{"nctId":"NCT02811484","phase":"PHASE4","title":"Efficacy of Exenatide-LAR and Dapagliflozin in Overweight/Obese, Insulin Treated Patients With Type 2 Diabetes","status":"WITHDRAWN","sponsor":"Weill Medical College of Cornell University","startDate":"2016-06","conditions":"Diabetes Mellitus, Type 2","enrollment":""},{"nctId":"NCT02459249","phase":"NA","title":"Metabolic Syndrome Diagnosis and Treatment for Adults of Low Socioeconomic Status Communities","status":"UNKNOWN","sponsor":"Mexican National Institute of Public Health","startDate":"2015-04","conditions":"Obesity, High Blood Pressure, Hyperglycemia","enrollment":120},{"nctId":"NCT01894074","phase":"NA","title":"The Effects of an Intensive Lifestyle Intervention on Reproductive Outcomes","status":"COMPLETED","sponsor":"Amy E Rothberg","startDate":"2013-07","conditions":"Subfertility, Anovulatory, Obese","enrollment":14},{"nctId":"NCT01436916","phase":"PHASE4","title":"Oral Cholecalciferol in Prevention of Type 2 Diabetes Mellitus","status":"COMPLETED","sponsor":"Post Graduate Institute of Medical Education and Research, Chandigarh","startDate":"2011-09","conditions":"Prediabetes, Vitamin D Deficiency","enrollment":50},{"nctId":"NCT02540382","phase":"NA","title":"Comparison of Covered and Bare Stent in TIPS","status":"COMPLETED","sponsor":"Beijing Shijitan Hospital, Capital Medical University","startDate":"2006-01","conditions":"Cirrhosis","enrollment":258},{"nctId":"NCT01666990","phase":"PHASE1, PHASE2","title":"Tripterygium Wilfordii Hook F (TwHF) Treatment for Immune Non-responders With HIV-1 Infection","status":"UNKNOWN","sponsor":"Beijing 302 Hospital","startDate":"2012-06","conditions":"Human Immunodeficiency Virus","enrollment":60},{"nctId":"NCT00263640","phase":"PHASE3","title":"Safety and Efficacy of House Dust Mite Allergoid in the Treatment of Bronchial Asthma","status":"COMPLETED","sponsor":"Allergopharma GmbH & Co. KG","startDate":"2005-05","conditions":"Respiratory Hypersensitivity","enrollment":130},{"nctId":"NCT00456521","phase":"PHASE3","title":"A Safety and Efficacy Study of Naltrexone SR/Bupropion SR and Placebo in Overweight and Obese Subjects Participating in an Intensive Behavior Modification Program","status":"COMPLETED","sponsor":"Orexigen Therapeutics, Inc","startDate":"2007-03","conditions":"Obesity, Overweight","enrollment":793},{"nctId":"NCT01448174","phase":"PHASE4","title":"Salusin-alpha - a New Factor in the Pathogenesis of Lipid Abnormalities in Hemodialysis Patients","status":"COMPLETED","sponsor":"Poznan University of Medical Sciences","startDate":"2011-10","conditions":"Renal Failure Chronic Requiring Hemodialysis, Metabolic Syndrome, Diabetes Mellitus Type 2","enrollment":310},{"nctId":"NCT00065806","phase":"PHASE3","title":"Atherosclerosis Prevention in Pediatric Lupus Erythematosus (APPLE)","status":"COMPLETED","sponsor":"Laura Schanberg","startDate":"2003-09","conditions":"Lupus Erythematosus, Systemic","enrollment":221},{"nctId":"NCT01711476","phase":"NA","title":"Meal Timing on Glucose and Hyperandrogenism in PCOS Women","status":"UNKNOWN","sponsor":"Hospital de Clinicas Caracas","startDate":"2012-10","conditions":"Polycystic Ovary Syndrome (PCOS) Women","enrollment":60},{"nctId":"NCT00167700","phase":"NA","title":"Pre-, Peri- and Postnatal Programming and Origins of Disease: Early Targeting the Epidemics of Allergy and Overweight","status":"UNKNOWN","sponsor":"University of Turku","startDate":"1997-02","conditions":"Allergic Disease, Obesity, Immunology","enrollment":800},{"nctId":"NCT00541710","phase":"PHASE2, PHASE3","title":"Effect of Genistein in Women With Metabolic Syndrome","status":"COMPLETED","sponsor":"University of Messina","startDate":"2007-10","conditions":"Metabolic Syndrome","enrollment":120},{"nctId":"NCT01664650","phase":"PHASE2, PHASE3","title":"Effects of Genistein in Postmenopausal Women With Metabolic Syndrome","status":"COMPLETED","sponsor":"University of Messina","startDate":"2008-09","conditions":"Metabolic Syndrome","enrollment":120},{"nctId":"NCT00820651","phase":"PHASE3","title":"Efficacy and Safety of Diamel in Patients With Nonalcoholic Steatohepatitis","status":"COMPLETED","sponsor":"Catalysis SL","startDate":"2009-11","conditions":"Nonalcoholic Steatohepatitis, Insulin Resistance","enrollment":158},{"nctId":"NCT01427218","phase":"NA","title":"Monitoring and Adjustment of Medication Therapy for Patients With Heart Disease","status":"UNKNOWN","sponsor":"Middle Tennessee Research Institute","startDate":"2010-11","conditions":"Coronary Heart Disease, Myocardial Infarction","enrollment":170},{"nctId":"NCT00917449","phase":"PHASE3","title":"Prevention of Type 2 Diabetes Mellitus by L-Arginine in Patients With Metabolic Syndrome","status":"COMPLETED","sponsor":"IRCCS San Raffaele","startDate":"2005-12","conditions":"Metabolic Syndrome, Impaired Glucose Tolerance, Insulin Resistance","enrollment":142},{"nctId":"NCT00252772","phase":"PHASE3","title":"GALLANT 2 Tesaglitazar vs. Placebo","status":"TERMINATED","sponsor":"AstraZeneca","startDate":"2004-09","conditions":"Type 2 Diabetes","enrollment":80},{"nctId":"NCT00690326","phase":"NA","title":"Behavioral Change Communication (BCC) to Promote Physical Activity Among Females With Type 2 Diabetes Mellitus Attending Diabetic Clinic","status":"COMPLETED","sponsor":"Thiruvananthapuram Medical College","startDate":"2006-05","conditions":"Type 2 Diabetes Mellitus","enrollment":86},{"nctId":"NCT00679679","phase":"PHASE4","title":"Metformin and Lifestyle Intervention in Women With Polycystic Ovary Syndrome","status":"COMPLETED","sponsor":"Hospital Privado de Cordoba, Argentina","startDate":"2003-01","conditions":"Polycystic Ovary Syndrome","enrollment":30},{"nctId":"NCT00263965","phase":"PHASE2","title":"ARAMIS: Actions of tesaglitazaR on fAt Metabolism and Insulin Sensitivity","status":"TERMINATED","sponsor":"AstraZeneca","startDate":"2005-08","conditions":"Type 2 Diabetes","enrollment":105},{"nctId":"NCT00252837","phase":"PHASE3","title":"GALLANT 22 Tesaglitazar vs. Placebo","status":"TERMINATED","sponsor":"AstraZeneca","startDate":"2005-04","conditions":"Type 2 Diabetes","enrollment":475}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"placebo + life style counselling","genericName":"placebo + life style counselling","companyName":"Post Graduate Institute of Medical Education and Research, Chandigarh","companyId":"post-graduate-institute-of-medical-education-and-research-chandigarh","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Placebo combined with lifestyle counseling works through behavioral modification and expectancy effects to improve health outcomes. Used for Lifestyle-related chronic disease prevention and management (e.g., metabolic syndrome, hypertension, obesity).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}